Skip to main content
COAG
NASDAQ Life Sciences

Hemab Therapeutics Reports Q1 Net Loss of $(22.7)M, EPS $(23.98) Post-IPO

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$26.3
Mkt Cap
$1.228B
52W Low
$23
52W High
$32
52W Position info
14% above low
Off High info
18% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

COAG is trading near its 52-week low of $23 (14% above the low).

Summary

Hemab Therapeutics reported a Q1 2026 net loss of $(22.7) million and diluted EPS of $(23.98). This is the company's first public earnings report following its IPO in early May. While the net loss widened compared to the prior year, the company's earlier 8-K today confirmed that IPO proceeds provide a cash runway into 2029, which is critical for funding its ongoing clinical development programs.

At the time of this announcement, COAG was trading at $26.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $23.00 to $32.00. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

COAG - Latest Insights

COAG
Nov 10, 2026, 7:08 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $42.81
Real-time Price: $39.38 info
Change: -$3.43 (-8%) info
Market Cap: $1.84B info
COAG
Nov 04, 2026, 9:05 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $43.10
Real-time Price: $39.38 info
Change: -$3.72 (-9%) info
Market Cap: $1.84B info
COAG
Sep 17, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $40.97
Real-time Price: $39.38 info
Change: -$1.59 (-4%) info
Market Cap: $1.84B info
COAG
Aug 11, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $51.74
Real-time Price: $39.38 info
Change: -$12.36 (-24%) info
Market Cap: $1.84B info
COAG
Aug 11, 2026, 7:50 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $49.87
Real-time Price: $39.38 info
Change: -$10.49 (-21%) info
Market Cap: $1.84B info